These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18949260)

  • 1. Multiple sclerosis outcome and morbi-mortality of a Brazilian cohort patients.
    Alves-Leon SV; Malfetano FR; Pimentel ML; Estrada CL; Pereira VC; Liem AM; Novis SA
    Arq Neuropsiquiatr; 2008 Sep; 66(3B):671-7. PubMed ID: 18949260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of secondary-progressive multiple sclerosis.
    Tremlett H; Yinshan Zhao ; Devonshire V
    Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of clinical characteristics for 'benign' multiple sclerosis.
    Ramsaransing GS; De Keyser J
    Eur J Neurol; 2007 Aug; 14(8):885-9. PubMed ID: 17662009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different cognitive profiles of Brazilian patients with relapsing-remitting and primary progressive multiple sclerosis.
    Rodrigues DN; Paes RA; Vasconcelos CC; Landeira-Fernandez J; Alvarenga MP
    Arq Neuropsiquiatr; 2011 Aug; 69(4):590-5. PubMed ID: 21877025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of multiple sclerosis in aboriginals living in British Columbia, Canada.
    Saeedi J; Rieckmann P; Yee I; Tremlett H;
    Mult Scler; 2012 Sep; 18(9):1239-43. PubMed ID: 22383230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.
    Kingwell E; van der Kop M; Zhao Y; Shirani A; Zhu F; Oger J; Tremlett H
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):61-6. PubMed ID: 21865212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway.
    Grytten Torkildsen N; Lie SA; Aarseth JH; Nyland H; Myhr KM
    Mult Scler; 2008 Nov; 14(9):1191-8. PubMed ID: 18632781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis: report on 200 cases from Curitiba, Southern Brazil and comparison with other Brazilian series.
    Arruda WO; Scola RH; Teive HA; Werneck LC
    Arq Neuropsiquiatr; 2001 Jun; 59(2-A):165-70. PubMed ID: 11400018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of multiple sclerosis in Santiago de Compostela (Spain).
    Costa Arpín E; Naveiro Soneira J; Lema Bouzas M; González Quintela A; Prieto González JM
    Acta Neurol Scand; 2020 Sep; 142(3):267-274. PubMed ID: 32392359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment after three decades of multiple sclerosis.
    Smestad C; Sandvik L; Landrø NI; Celius EG
    Eur J Neurol; 2010 Mar; 17(3):499-505. PubMed ID: 20050887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
    Sayao AL; Devonshire V; Tremlett H
    Neurology; 2007 Feb; 68(7):496-500. PubMed ID: 17296915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of epilepsy in multiple sclerosis.
    Mahamud Z; Burman J; Zelano J
    Mult Scler Relat Disord; 2020 Feb; 38():101497. PubMed ID: 31726355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of multiple sclerosis with early onset.
    Ghezzi A; Pozzilli C; Liguori M; Marrosu MG; Milani N; Milanese C; Simone I; Zaffaroni M
    Mult Scler; 2002 Apr; 8(2):115-8. PubMed ID: 11990867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapses and progression of disability in multiple sclerosis.
    Confavreux C; Vukusic S; Moreau T; Adeleine P
    N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
    Sayao AL; Bueno AM; Devonshire V; Tremlett H;
    Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival of patients with multiple sclerosis in West France.
    Leray E; Morrissey S; Yaouanq J; Coustans M; Le Page E; Chaperon J; Edan G
    Mult Scler; 2007 Aug; 13(7):865-74. PubMed ID: 17881399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience.
    Mancardi GL; Sormani MP; Di Gioia M; Vuolo L; Gualandi F; Amato MP; Capello E; Currò D; Uccelli A; Bertolotto A; Gasperini C; Lugaresi A; Merelli E; Meucci G; Motti L; Tola MR; Scarpini E; Repice AM; Massacesi L; Saccardi R;
    Mult Scler; 2012 Jun; 18(6):835-42. PubMed ID: 22127896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.
    Sola P; Mandrioli J; Simone AM; Ferraro D; Bedin R; Annecca R; Venneri MG; Nichelli PF; Merelli E
    Mult Scler; 2011 Mar; 17(3):303-11. PubMed ID: 21078694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis.
    Holmén C; Piehl F; Hillert J; Fogdell-Hahn A; Lundkvist M; Karlberg E; Nilsson P; Dahle C; Feltelius N; Svenningsson A; Lycke J; Olsson T
    Mult Scler; 2011 Jun; 17(6):708-19. PubMed ID: 21228027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.